new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Amylin Pharmaceuticals Inc
Amylin Pharmaceuticals Inc_20100114
  

Amylin Pharmaceuticals Inc patents

Recent patent applications related to Amylin Pharmaceuticals Inc. Amylin Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Amylin Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Amylin Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Amylin Pharmaceuticals Inc-related inventors




Date Amylin Pharmaceuticals Inc patents (updated weekly) - BOOKMARK this page
04/18/13Hypodermic needle assembly having a transition hub for enhancing fluid dynamics and microsphere injectability
11/29/12Treatment of diabetic cardiomyopathy with a glp-1 peptide
11/22/12Glp-1 receptor agonist compounds for obstructive sleep apnea
11/22/12Glp-1 receptor agonists to treat pancreatitis
11/22/12Mixing tool
10/04/12Hybrid polypeptides with selectable properties
09/13/12Glp-1 receptor agonist compounds for sleep enhancement
08/02/12Amylin family peptides and methods for making and using them
08/02/12Amylin family peptides and methods for making and using them
05/31/12Modified exendins and exendin agonists
03/01/12Methods for affecting body composition using amylin agonists
02/23/12N-terminus conformationally constrained glp-1 receptor agonist compounds
01/05/12Exendins and exendin agonist analogs to regulate gastrointestinal motility
12/15/11Glp-1 receptor agonists to treat pancreatitis
11/24/11Amylin and amylin agonists for treating psychiatric diseases and disorders
11/17/11Methods for lowering plasma glucagon with exendins and exendin agonist analogs
10/27/11Compositions and methods for the control, prevention and treatment of obesity and eating disorders
10/27/11Exendins to lower cholesterol and triglycerides
10/06/11Methods for treating diabetes and reducing body weight
08/11/11Methods of treatment using exendin peptides or glp-1 peptides
07/21/11Prevention and treatment of cardiac arrhythmias
06/09/11Dpp-iv resistant gip hybrid polypeptides with selectable properties
04/28/11Glp-1 receptor agonist bioassays
03/24/11Novel exendin agonist compounds
02/10/11Exendin and exendin agonists for eating disorders
12/23/10Methods for treating obesity and obesity related diseases and disorders
12/09/10Treatment of acute coronary syndrome with an exendin
11/25/10Pen injection device and using same
11/18/10Peptide-peptidase inhibitor conjugates and methods of using same
11/11/10Peptide-peptidase-inhibitor conjugates and methods of making and using same
08/19/10Drug delivery device
07/29/10Mixing tool
07/01/10Pharmaceutical formulations and methods for making the same
07/01/10Neuromedin and fn-38 peptides for treating psychiatric diseases
05/20/10Amylin and amylin agonists for treating psychiatric diseases and disorders
04/22/10Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
04/15/10Formulation delivery device
02/04/10Composition and methods for treatment of congestive heart failure
01/14/10Glucagon-like peptides and uses thereof
12/17/09Uses of glucoregulatory proteins
11/26/09Transmucosal delivery of peptides and proteins
11/19/09Hybrid polypeptides with selectable properties
10/01/09Polymer-based sustained release device
09/24/09Methods for treating diabetes and reducing body weight
08/27/09Lyophilized formulations of exendins and exendin agonist analogs
08/20/09Compositions and methods for treating obesity and related metabolic disorders
08/13/09Methods to restore glycemic control
08/13/09Compositions for the treatment and prevention of nephropathy
07/23/09Peptide-peptidase inhibitor conjugates and methods of using same
07/16/09Amylin and amylin agonists for treating psychiatric diseases and disorders
07/09/09Exendin agonist analogs to treat diabetes
06/25/09Exendins and exendin agonist analogs to regulate gastrointestinal motility
06/18/09Methods for treating obesity and obesity related diseases and disorders
05/28/09Use of glp-1, exendin and agonists thereof to delay or prevent cardiac remodeling
03/12/09Transmucosal delivery of peptides and proteins
03/05/09Compositions and methods for the control, prevention and treatment of obesity and eating disorders
02/26/09Methods of treatment using exendin peptides or glp-1 peptides
02/05/09Gip analog and hybrid polypeptides with selectable properties
01/14/10Glucagon-like peptides and uses thereof







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Amylin Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Amylin Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';